Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 3421 AL 3435

Air pollution and your brain: what do you need to know right now

Calderón-Garcidueñas L, Calderón-Garcidueñas A, Torres-Jardón R, Avila-Ramírez J, Kulesza RJ, Angiulli AD.

Prim Health Care Res Dev. 2015 Jul;16(4):329-45. doi: 10.1017/S146342361400036X. Epub 2014 Sep 26.

Comparing the Fullerton Advanced Balance Scale with the Mini-BESTest and Berg Balance Scale to assess postural control in patients with Parkinson disease

Schlenstedt C, Brombacher S, Hartwigsen G, Weisser B, Möller B, Deuschl G.

Arch Phys Med Rehabil. 2015 Feb;96(2):218-25. doi: 10.1016/j.apmr.2014.09.002. Epub 2014 Sep 28.

Parkinson's disease and age: The obvious but largely unexplored link

Abdullah R, Basak I, Patil KS, Alves G, Larsen JP, Møller SG.

Exp Gerontol. 2015 Aug;68:33-8. doi: 10.1016/j.exger.2014.09.014. Epub 2014 Sep 26.

Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?

Marwarha G, Ghribi O.

Exp Gerontol. 2015 Aug;68:13-8. doi: 10.1016/j.exger.2014.09.013. Epub 2014 Sep 28.

Restless legs syndrome in patients with Parkinson's disease: a comparative study on prevalence, clinical characteristics, quality of life and nutritional status

Fereshtehnejad SM, Shafieesabet M, Shahidi GA, Delbari A, Lökk J.

Acta Neurol Scand. 2015 Apr;131(4):211-8. doi: 10.1111/ane.12307. Epub 2014 Sep 28.

Presence of septal Q waves in a patient with WPW and manifest preexcitation

Tandon D, Scheinman MM, Badhwar N.

Ann Noninvasive Electrocardiol. 2015 May;20(3):296-8. doi: 10.1111/anec.12211. Epub 2014 Sep 30.

Central pharmacokinetics of levodopa: Lessons from imaging studies

Stoessl AJ.

Mov Disord. 2015 Jan;30(1):73-9. doi: 10.1002/mds.26046. Epub 2014 Oct 1.

Taste in Parkinson's disease

Cecchini MP, Fasano A, Boschi F, Osculati F, Tinazzi M.

J Neurol. 2015;262(4):806-13. doi: 10.1007/s00415-014-7518-1. Epub 2014 Oct 4.

What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?

Lue LF, Schmitz C, Walker DG.

Neuroscience. 2015 Aug 27;302:138-50. doi: 10.1016/j.neuroscience.2014.09.050. Epub 2014 Oct 2.

The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease

Schapansky J, Nardozzi JD, LaVoie MJ.

Neuroscience. 2015 Aug 27;302:74-88. doi: 10.1016/j.neuroscience.2014.09.049. Epub 2014 Oct 2.

Interaction of noradrenergic pharmacological manipulation and subthalamic stimulation on movement initiation control in Parkinson's disease

Albares M, Thobois S, Favre E, Broussolle E, Polo G, Domenech P, Boulinguez P, Ballanger B.

Brain Stimul. 2015 Jan-Feb;8(1):27-35. doi: 10.1016/j.brs.2014.09.002. Epub 2014 Sep 15.

Parkinsonian gait ameliorated with a moving handrail, not with a banister

Rabin E, Demin A, Pirrotta S, Chen J, Patel H, Bhambri A, Noyola E, Lackner JR, DiZio P, DiFrancisco-Donoghue J, Werner W.

Arch Phys Med Rehabil. 2015 Apr;96(4):735-41. doi: 10.1016/j.apmr.2014.07.427. Epub 2014 Oct 5.

Effects of levodopa on regional cerebral metabolism and blood flow

Ko JH, Lerner RP, Eidelberg D.

Mov Disord. 2015 Jan;30(1):54-63. doi: 10.1002/mds.26041. Epub 2014 Oct 9.

Parkinson's disease, the subthalamic nucleus, inhibition, and impulsivity

Jahanshahi M, Obeso I, Baunez C, Alegre M, Krack P.

Mov Disord. 2015 Feb;30(2):128-40. doi: 10.1002/mds.26049. Epub 2014 Oct 9.

Evaluation of measures of upper limb functioning and disability in people with Parkinson disease: a systematic review

Proud EL, Miller KJ, Bilney B, Balachandran S, McGinley JL, Morris ME.

Arch Phys Med Rehabil. 2015 Mar;96(3):540-551.e1. doi: 10.1016/j.apmr.2014.09.016. Epub 2014 Oct 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias